The invention also relates to a drug containing the required conjugate of formula ().The use of the pharmaceutical composition, the conjugate of formula (I) in the medicine and the medicine presenting G-CSF blood growth factor as the active substance, the method of preventing and / or ...
产品规格 目录价 数量 91105ES10 10 μg 1665.00 91105ES60 100 μg 10835.00 91105ES76 500 μg 23885.00 批量采购,请点击询价 下载产品说明书 产品说明书 FAQ COA 已发表文献 G-CSF is a hematopoietic growth factor that stimulates the development of committed progenitor cells to neutrophils and enhances...
GM-CSF在肿瘤治疗中的双重作用可能存在多种作用机制,Tim D. Eubank等研究显示瘤内注射GM-CSF可逆转“Tumor education”的部分结果,GM-CSF主要通过刺激单核细胞分泌游离型血管内皮生长因子受体-1(soluble vascular endothelial growth factor receptor-1, sVEGFR-1)抑制巨噬细胞中血管内VEGF的活性,减少乳腺肿瘤新生血管...
别名G-CSF; Colony Stimulating Factor 3; Granulocyte; GCSF 商品属性 标签无标签 表达宿主大肠杆菌 种属小鼠 序列氨基酸序列来源于:重组小鼠粒细胞集落刺激因子(G-CSF) (P09920) (V31-A208) 表达的蛋白片段。 活性通过其诱导M-NFS-60细胞增殖的能力来测定。ED50为2.038 pg/mL。
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein hemopoietic growth factor that regulates the survival, proliferation, differentiation, and function of neutrophils and their precursors (for a review, see ref. 1). Neutrophils are the most common granulocytic cell found in the blood and...
重组小鼠粒细胞集落刺激因子(G-CSF) 英文名称: Recombinant Mouse Granulocyte Colony-Stimulating Factor 总访问: 233 国产/进口: 国产 半年访问: 29 产地/品牌: 百奥莱博 产品类别: 分子生物学试剂 规格: JN1067 最后更新: 2025-2-13 货号: JN1067 CAS 号: 参考报价: 立即询价 电话咨询 ...
2014年ASBMT(美国血液与骨髓移植学会)提到粒细胞集落刺激因子(G-CSF)联合普乐沙福一线稳态动员是预防再动员的可靠策略,所有患者均适合一线应用普乐沙福,尤其适合追求更高CD34+细胞数,实时监测外周血CD34+细胞数不可得和需要缩短采集天数...
The hematopoietic growth factor G-CSF is likely to soon become an integral part of various oncologic and other therapeutic regimens. As part of chemotherap
粒细胞集落刺激因子(G-CSF)是 CSF 系列糖蛋白中的一种,可调节造血细胞的增殖、分化和功能。它是一种关键的细胞因子,参与中性粒细胞的生成,并刺激造血祖细胞形成粒细胞集落(Metcalf 和 Nicola)。G-CSF 可产生一系列效应,包括一过性减少 SDF-1 的表达、激活能裂解 VCAM-1 的金属蛋白酶、从交感神经系统释放,从...
Recombinant G-CSF (8 micrograms/kg) was administered subcutaneously over a minimum of 4 days. Peripheral blood control were performed prior to administration of G-CSF (day 0), the third (day +3) day, and the sixth day (day +6). Daily leukapheresis was initiated at d...